NYSE American - Nasdaq Real Time Price USD
NeurAxis, Inc. (NRXS)
2.4000
-0.0168
(-0.70%)
As of 11:58:03 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.17M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HANNASCH BRIAN Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.73 per share. | Direct | 31,251 | Apr 21, 2025 |
| FERGE KRISTIN A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 28, 2024 |
| WATKINS BRADLEY MITCHELL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 28, 2024 |
| KEYSER JANE ELIZABETH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 28, 2024 |
| HANNASCH BRIAN Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2024 |
| HANNASCH BRIAN Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.61 per share. | Direct | 198 | Dec 28, 2023 |
| HANNASCH BRIAN Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 0.00 per share. | Direct | 200 | Dec 28, 2023 |
| MASIMO CORP. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Aug 11, 2023 |
| MASIMO CORP. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Aug 10, 2023 |
Related Tickers
SCPS Scopus BioPharma Inc.
0.0003
0.00%
TELI.CN Telescope Innovations Corp.
0.2600
0.00%
BRNS Barinthus Biotherapeutics plc
0.8400
+8.67%
ICCC ImmuCell Corporation
5.38
-2.13%
EPRX Eupraxia Pharmaceuticals Inc.
4.0000
+4.17%
EVGN.TA Evogene Ltd.
389.00
-7.49%
LIXT Lixte Biotechnology Holdings, Inc.
1.2800
-2.29%
RNTX Rein Therapeutics Inc.
1.7800
-2.20%
NAYA INVO Fertility, Inc.
2.0800
+8.33%
ENTO Entero Therapeutics, Inc.
0.3641
+0.61%